InsidersTradesSigma
Total declarations
Company
▲ Purchases (5 ops.)
▼ Sales (0 ops.)
Insider track record
CFODisclosed buys
5
Disclosed sells
0
Not enough buy signals with a settled T+90 horizon to measure a track record yet.
Signal history
Browse the detailed record of transactions filed by CHAUSSY STEVE, Chief Financial Officer. Director active across 1 company, notably BioSig Technologies, Inc.. Cumulatively, 6 disclosures have been recorded. Breakdown: 5 buys · 0 sell. Total volume traded: €28k. History available since 21 May 2021. The latest transaction was filed on 1 September 2022 (Acquisition). Regulator: SEC (Form 4). The full history is openly available.
Declarations6 total
11,425 shares@ US$1.131647.1% of flowCommon StockSEC:0001185185-22-001054:0
Ideal exit: 29 May 2023 (T+270)
8,000 shares@ US$1.12732.9% of flowCommon StockSEC:0001185185-22-001002:0
Ideal exit: 19 May 2023 (T+270)
1,000 shares@ US$3.3950.0% of flowCommon StockSEC:0001185185-21-000712:0
Ideal exit: 15 Feb 2022 (T+270)
1,000 shares@ US$3.3950.0% of flowCommon StockSEC:0001185185-21-000712
Ideal exit: 15 Feb 2022 (T+270)
75,000 sharesCommon Stock, $0.001 par value per shareSEC:0001185185-16-003479:0
3,000 sharesCommon Stock, $0.001 par value per shareSEC:0001185185-16-003479:1
Ideal exit: 8 Oct 2016 (T+270)
6 of 6 declarations
About CHAUSSY STEVE
Steve Chaussey serves as Chief Financial Officer at BioSig Technologies, Inc. He manages the financial operations and strategy of the company, which specializes in medical technologies. Steve Chaussey plays a crucial role in financial planning and performance analysis.
